Global Orphan Drugs Market is Anticipated to Cross USD 350 Billion by 2032 | DelveInsight
PR Newswire —
The orphan drugs market is seeing strong expansion, propelled by the growing worldwide incidence of genetic conditions and other rare diseases, as well as the substantial unmet need for effective therapies. With many rare disorders still lacking adequate treatment options, the market...